Recent advances in understanding and treating vasculitis [version 1; referees: 2 approved]
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are near universally fatal conditions if untreated. Although effective therapeutic options are available for these diseases, treatment regimens are associated with both short- and long-term adverse effects. The recent identif...
Main Authors: | Matthew J. Koster, Kenneth J. Warrington |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2016-06-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | http://f1000research.com/articles/5-1436/v1 |
Similar Items
-
Recent advances in understanding and treating nephrotic syndrome [version 1; referees: 2 approved]
by: Agnieszka Bierzynska, et al.
Published: (2017-02-01) -
Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis [version 1; referees: 2 approved]
by: Susan Yung, et al.
Published: (2017-06-01) -
Recent advances in primary Sjogren's syndrome [version 1; referees: 3 approved]
by: Nicholas Holdgate, et al.
Published: (2016-06-01) -
Recent advances in understanding and managing psoriatic arthritis [version 1; referees: 2 approved]
by: Dafna D. Gladman
Published: (2016-11-01) -
B-cell tolerance and autoimmunity [version 1; referees: 2 approved]
by: Takeshi Tsubata
Published: (2017-03-01)